Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: A case-control study and a meta-analysis

BMC Pregnancy and Childbirth

Volumn 6, Issue , 2006, Pages

  Yu, Christina K H ^a   Casas, Juan P ^b,c   Savvidou, Makrina D ^a   Sahemey, Manpreet K ^b   Nicolaides, Kypros H ^a   Hingorani, Aroon D ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; DNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMIC ACID;

AFRICAN CARIBBEAN; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; ASIAN; BODY MASS; CASE CONTROL STUDY; CAUCASIAN; CIGARETTE SMOKING; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; EMBASE; ETHNIC DIFFERENCE; FEMALE; GENERAL HOSPITAL; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GESTATION PERIOD; HIGH RISK PATIENT; HOMOZYGOSITY; HUMAN; HUMAN CELL; LASER DOPPLER FLOWMETRY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MEDLINE; PARITY; PATHOGENESIS; PREECLAMPSIA; PREGNANCY; RISK ASSESSMENT; SAMPLE SIZE; UNITED KINGDOM; UTERINE ARTERY;

EID: 33645542061     PISSN: 14712393     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-6-7     Document Type: Article

References (42)

1. Robson SC, Hunter S, Boys RJ, Dunlop W: Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol 1989, 256:H1060-5.
2. Williams DJ, Vallance PJ, Neild GH, Spencer JA, Imms FJ: Nitric oxide-mediated vasodilation in human pregnancy. Am J Physiol 1997, 272:H748-52.
3. Hingorani AD: Endothelial nitric oxide synthase polymorphisms and hypertension. Curr Hypertens Rep 2003, 5:19-25.
4. Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB: The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1994, 171:944-8.
5. Choi JW, Im MW, Pai SH: Nitric oxide production increases during normal pregnancy and decreases in preeclampsia. Ann Clin Lab Sci 2002, 32:257-63.
6. Salonen Ros H, Lichtenstein P, Lipworth L, Cnattingius S: Genetic effects on the liability of developing pre-eclampsia and gestational hypertension. Am J Med Genet 2000, 91:256-60.
7. Krotz S, Fajardo J, Ghandi S, Patel A, Keith LG: Hypertensive disease in twin pregnancies: a review. Twin Res 2002, 5:8-14.
8. Lachmeijer AM, Arngrimsson R, Bastiaans EJ: Mutations in the gene for methylenetetrahydrofolate reductase, homocysteine levels, and vitamins status in women with a history of pre-eclampsia. Am J Obstet Gynecol 2001, 184:394-402.
9. Morgan L, Crawshaw S, Baker PN: Maternal and fetal angiotensinogen gene allele sharing in pre-eclampsia. Br J Obstet Gynaecol 1999, 106:244-251.
10. Kosmas IP, Tatsioni A, Ioannidis JP: Association of Leiden mutation in factor V gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens 2003, 21:1221-8.
11. Colhoun HM, McKeigue PM, Davey Smith G: Problems of reporting genetic associations with complex outcomes. Lancet 2003, 361:865-72.
12. Savvidou MD, Valiance PJ, Nicolaides KH, Hingorani AD: Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy. Hypertension 2001, 38:1289-93.
13. Casas JP, Bautista LE, Humphries SE, Hingorani AD: Endothelial Nitric Oxide Synthase Genotype and Ischemic Heart Disease: Meta-Anaiysis of 26 Studies Involving 23028 Subjects. Circulation 2004, 109:1359-1365.
14. Smith GC, Pell JP, Walsh D: Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001, 357:2002-6.
15. Yoshimura T, Yoshimura M, Tabata A, Shimasaki Y, Nakayama M, Miyamoto Y, Saito Y, Nakao K, Yasue H, Okamura H: Association of the missense Glu298Asp variant of the enclothelial nitric oxide synthase gene with severe preeclampsia. J Soc Gynecol Investig 2000, 7:238-41.
16. Kobashi G, Yamada H, Ohta K, Kato E, Ebina Y, Fujimoto S: Endothelial nitric oxide synthase gene (NOS3) variant and hypertension in pregnancy. Am J Med Genet 2001, 103:241-4.
17. Hakli T, Romppanen EL, Hiltunen M, Helisalmi S, Punnonen K, Heinonen S: Endothelial nitric oxide synthase polymorphism in preeclampsia. J Soc Gynecol Investig 2003, 10:154-7.
18. Yoshimura T, Chowdhury FA, Yoshimura M, Okamura H: Genetic and Environmental Contributions to Severe Preeclampsia: Lack of Association with the Endothelial Nitric Oxide Synthase Glu298Asp Variant in a Developing Country. Gynecol Obstet Invest 2003, 56:10-3.
19. Landau R, Xie HG, Dishy V, Wood AJ, Stein CM, Smiley RM: No association of the Asp298 variant of the enclothelial nitric oxide synthase gene with preeclampsia. Am J Hypertens 2004, 17:391-4.
20. Ohta K, Kobashi G, Hata A, Yamada H, Minakami H, Fujimoto S, Kondo K, Tamashiro H: Association between a variant of the glutathione S-transferase PI gene (GSTPI) and hypertension in pregnancy in Japanese: interaction with parity, age, and genetic factors. Semin Thromb Hemost 2003, 29:653-9.
21. Tempfer CB, Jirecek S, Katrin Riener E, Zeisler H, Denschlag D, Hefler L, Husslein PW: Polymorphisms of thrombophilic and vasoactive genes and severe preeclampsia: a pilot study. J Soc Gynecol Investig 2004, 11:227-31.
22. Watanabe H, Hamada H, Yamakawa-Kobayashi K, Yoshikawa H, Arinami T: Evidence for an association of the R485K polymorphism in the coagulation factor V gene with severe preeclampsia from screening 35 polymorphisms in 27 candidate genes. Thromb Haemost 2001, 86:1594-5.
23. Serrano NC, Casas JP, Díaz LA, Páez C, Mesa CM, Cifuentes R, Monterrosa M, Bautista A, Hawe E, Hingorani AD, Valiance P, López-Jaramillo P: Endothelial Nitric Oxide Synthase Genotype and Risk of Preeclampsia: a multi-centre case-control study. Hypertension 2004, 44:702-707.
24. Yu CK, Papageorghiou AT, Parra M, Palma Dias R, Nicolaides KH, Fetal Medicine Foundation Second Trimester Screening Group: Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation. Ultrasound in Obstet Gynecol 2003, 22:233-9.
25. Papageorghiou AT, Yu CK, Bindra R, Pandis G, Nicolaides KH, Fetal Medicine Foundation Second Trimester Screening Group: Multi-center screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 2001, 18:441-9.
26. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM: The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001, 20:IX-XIV.
27. Shadish WR, Haddock CK: Combining estimates of effect size. In The handbook of Research Synthesis Edited by: Cooper H, Hedges LV. New York: Rusell Sage Foundation; 1994:261-284.
28. DerSimonian R, Laird NM: Meta-analysis in clinical trials. Controlled Clinical Trials 1986, 7:177-188.
29. Deeks JJ, Higgins JPT, Altman DG, editors: Analysing and presenting results. In: Alderson P, Green S, Higgins J, editors. Cochrane Reviewers' Handbook 4.2.2. 1986 [http://www.cochrane.org/resources/ handbook/hbook.htm]. (accessed 31st January 2005). [updated March 2004] Section 8
30. Egger M, Smith GD, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
31. Hillermann R, Carelse K, Gebhardt GS: The Glu298Asp variant of the endothelial nitric oxide synthase gene is associated with an increased risk for abruptio placentae in pre-eclampsia. J Hum Genet 2005, 50:415-9.
32. Kim YJ, Park HS, Lee HY, Ha EH, Suh SH, Oh SK, Yoo HS: Reduced I-arginine level and decreased placental eNOS activity in preeclampsia. Placenta in press. 2005 Jul 9
33. Savvidou MD, Hingorani AD, Tsikas D, Frolich JC, Valiance P, Nicolaides KH: Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 2003, 361:1511-7.
34. Hingorani AD: Polymorphisms in endothelial nitric oxide synthase and atherogenesis. Atherosclerosis 2001, 154:521-7.
35. Pridjian G, Puschett JB: Preeclampsia: Part 2: experimental and genetic considerations. Obstet Gynecol Surv 2002, 57:619-40.
36. Guo G, Lade JA, Wilton AN, Moses EK, Grehan M, Fu Y, Qiu H, Cooper DW, Brennecke SP: Genetic susceptibility to preeclampsia and chromosome 7q36. Hum Genet 1999, 105:641-7.
37. Lade JA, Moses EK, Guo G, Wilton AN, Grehan M, Cooper DW, Brennecke SP: The eNOS gene: a candidate for the preeclampsia susceptibility locus? Hypertens Pregnancy 1999, 18:81-93.
38. Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J: Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci USA 2000, 97:2832-5.
39. Persu A, Stoenoiu MS, Messiaen T, Davila S, Robino C, El-Khattabi O, Mourad M, Horie S, Feron O, Balligand JL, Wattiez R, Pirson Y, Chauveau D, Lens XM, Devuyst O: Modifier effect of eNOS in autosomal dominant polycystic kidney disease. Hum Mol Genet 2002, 11:229-241.
40. Fairchild TA, Fulton D, Fontana JT, Gratton JP, McCabe TJ, Sessa WC: Acidic hydrolysis as a mechanism for the cleavage of the Glu(298)->Asp variant of human endothelial nitric-oxide synthase. J Biol Chem 2001, 276:26674-9.
41. Casas JP, Hingorani AD, Bautista LE, Sharma P: Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol 2004, 61:1652-61.
42. Khoury MJ, Davis R, Gwinn M, Lindegren ML, Yoon P: Do we need genomic research for the prevention of common diseases with environmental causes? Am J Epidemiol 2005, 161:799-805.